Bioneer Corporation (KOSDAQ:064550)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,900
-70 (-0.64%)
Apr 28, 2026, 3:30 PM KST
-33.17%
Market Cap 281.33B
Revenue (ttm) 330.11B
Net Income (ttm) -2.81B
Shares Out 25.81M
EPS (ttm) -109.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 115,480
Average Volume 142,028
Open 11,100
Previous Close 10,970
Day's Range 10,870 - 11,250
52-Week Range 9,900 - 17,950
Beta 0.22
RSI 46.90
Earnings Date Apr 1, 2026

About Bioneer

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 367
Stock Exchange KOSDAQ
Ticker Symbol 064550
Full Company Profile

Financial Performance

In 2025, Bioneer's revenue was 330.11 billion, an increase of 12.29% compared to the previous year's 293.98 billion. Losses were -2.81 billion, -86.33% less than in 2024.

Financial Statements

News

There is no news available yet.